Financials
- Market Capitalization 14.55 M
- Employee 23
- Founded 2007
- CEO N/A
- Website www.citiuspharma.com
- Headquarter Nevada, United States
- FIGI BBG001QQH2N3
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-0.42
売上高対価格比率
3.49
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 4707 | HIND Vyome Holdings, Inc. - Common Stock | 2.18 USD | -2.68% | -1.80% | -0.91% | -84.71% | 15.30 M USD | ||
| 4715 | LEXX Lexaria Bioscience Corp. - Common Stock | 0.59 USD | 0.00% | +7.27% | -1.67% | -27.16% | 14.62 M USD | ||
| 4717 | TPST Tempest Therapeutics, Inc. - Common Stock | 0.98 USD | 0.00% | 0.00% | -21.60% | -59.00% | 14.51 M USD | ||
| 4720 | PASG Passage Bio, Inc. - Common Stock | 4.44 USD | -0.45% | -9.76% | -21.69% | -49.77% | 14.24 M USD |